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Abstract
Background: We describe a test for rapid detection of S. dysenteriae 1 in bacterial cultures and in stools, at the bedside of
patients.
Methodology/Principal Findings: The test is based on the detection of S. dysenteriae 1 lipopolysaccharide (LPS) using
serotype 1-specific monoclonal antibodies coupled to gold particles and displayed on a one-step immunochromatographic
dipstick. A concentration as low as 15 ng/ml of LPS was detected in distilled water and in reconstituted stools in 10 minutes.
In distilled water and in reconstituted stools, an unequivocal positive reaction was obtained with 1.6610
6 CFU/ml and
4.9610
6 CFU/ml of S. dysenteriae 1, respectively. Optimal conditions to read the test have been determined to limit the risk
of ambiguous results due to appearance of a faint yellow test band in some negative samples. The specificity was 100%
when tested with a battery of Shigella and unrelated strains in culture. When tested on 328 clinical samples in India,
Vietnam, Senegal and France by laboratory technicians and in Democratic Republic of Congo by a field technician, the
specificity (312/316) was 98.7% (95% CI:96.6–99.6%) and the sensitivity (11/12) was 91.7% (95% CI:59.8–99.6%). Stool
cultures and the immunochromatographic test showed concordant results in 98.4 % of cases (323/328) in comparative
studies. Positive and negative predictive values were 73.3% (95% CI:44.8–91.1%) and 99.7% (95% CI:98–100%).
Conclusion: The initial findings presented here for a simple dipstick-based test to diagnose S. dysenteriae 1 demonstrates its
promising potential to become a powerful tool for case management and epidemiological surveys.
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Introduction
Shigella is one of the most common bacterial agents of acute
diarrhoea. It has been estimated that 165 million cases of
shigellosis occur annually worldwide, resulting in 1.1 million
deaths, mainly in the Third World [1,2–5]. Among the numerous
Shigella serotypes, S. dysenteriae type 1 was the first described and
stands out for causing deadly epidemics in the most impoverished
areas, particularly in situation of natural disaster or war (i.e.
refugees camps, forced human displacement). A severity of
symptoms, high attack rate, high case-fatality rate in all age
groups [6–12] but especially in children under 5 years [7], and
various complications [13] are hallmark characteristics of infection
with the Shiga bacillus. This bacterium was responsible for large
dysentery epidemics in Guatemala and other parts of Zaire [14],
Central America [15], Bangladesh [16], Kenya [17], and recently
West Africa [18] and India [19]. In the last decade, epidemic S.
dysenteriae 1 strains resistant to ampicillin, chloramphenicol,
nalidixic acid, tetracycline, trimethoprim-sulfamethoxazole, and
only moderately susceptible to ciprofloxacin have been isolated
with increasing frequency in Africa and Asia [10,19,20,21], while
strains resistant to ciprofloxacin have recently been isolated in
India and Bangladesh, thus reducing the availability of effective
oral therapy [16,17].
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  Early diagnosis of acute enteric infections is currently a
significant clinical problem especially in areas of conflict or mass
displacement of susceptible persons, remains challenging [19,20].
Rapid test methods, in which the response is achieved relatively
quickly, are gaining in importance when timely antiepidemic
measures (quarantine, disinfection, examination of contacts) and
proper etiotropic therapy are needed [18,19,20]. Most rapid test
methods currently practiced have been devised to search for
antibodies to infectious agents in blood or in other biological fluids
of patients, and only some have been tailored for direct
identification of the pathogen. Obviously, these latter are more
favored from an epidemiologic standpoint. The rapid and sensitive
diagnosis of S. dysenteriae 1 is essential to be able to immediately
treat the patients, to provide chemoprophylaxis to the subjects in
contact with the pathogen, and to implement control measures to
stop microbial transmission. In order to achieve this, improved
diagnostic tools are needed to complete the currently used classical
microbiological methods. Such tests should be robust, quick,
reliable (sensitive and specific), efficient on fecal samples and easy
to use at the patient’s bedside or in the field.
Immunoassays are extremely simple to perform and have
become more common at resource-limited sites, particularly in the
form of lateral flow immunochromatographic devices [22].
Immunochromatographic techniques using dipsticks are based
on the recognition of pathogen-specific antigens by monoclonal
antibodies (mAbs). Such dipsticks have already been successfully
developed at Institut Pasteur for cholera [23], meningitidis [24],
plague [25] and S. flexneri 2a [26]. In this study, we investigated the
potential of the dipstick technology to detect S. dysenteriae 1i n
bacterial cultures and in stools. The dipstick is based on the
detection of lipopolysaccharide (LPS), the major bacterial surface
antigen. Indeed, Shigella serotypes are defined by the structure of
the oligosaccharide repeating unit (RU) that forms the O-antigen
(O-Ag), the polysaccharide moiety of LPS [27]. The O antigen of
S. dysenteriae type 1 is essential for virulence and there is indirect
evidence that antibodies against the O antigen are protective
[28,29]. The antigen consists of tetrasaccharide repeating units of
the following structure: R3)-a-L-Rhap-(1R3)- a-L-Rhap-(1R2)-a-
DGalp-(1R3)-a-D-GlcpNAc-(1R [30].
In this preliminary study, we demonstrate that a dipstick based
on mAbs recognition of serotype 1-specific determinants carried
by the LPS O-Ag, is a rapid, robust and reliable test to identify S.
dysenteriae 1 in bacterial cultures when used by laboratory
technicians. It has also been evaluated on stools in different
settings by laboratory and field technicians (dispensaries) with
encouraging results.
Materials and Methods
1. Ethics Statement
In India, Vietnam, Senegal and France, written informed
consent was obtained from all participants involved in the study.
This study was approved by the Institute Ethics Committee of
Postgraduate Institute of Medical education and Research in
Chandigarh (institutional review board included Girish Varshney,
Jatinder Mohan, Kusum Joshi, Sudesh Prabhakar, Rajesh Kumar,
Jai Dev Wig, Niranjan Khandelwal, Sanjay Jain, Sunil Arora,
Nirmal Kumar Ganguly, Prem Kumar Palli, Arunaloke Chakra-
barti), by the Ethics Committee of Senegal (national review board
included Moustapha Dieng, Djiby Faye, Cheikh Mbacke ´L o ˆ,
Aı ¨ssatou Toure ´, Charles Becker, Alassane Wade, Ismaila Gou-
diaby, Aldiouma Diallo, Malick Cisse ´, Mamadou Lamine Sow,
Ami Colle ´ Gueye, Birame Drame ´, Samba Cor Sarr, Mamadou
Lamine Badji, Pape Toure ´, Le ´on Diouf, Anta Tall Dia) and by the
Scientific and Ethical Committee of Pasteur Institute in Ho Chi
Minh City (institutional review board included Nguyen Van Tam,
Nguyen Kim Dung, Nguyen Thi Nguyet Thu, Cao Minh Thang,
Ho Thi Thien Ngan). In France, feces from healthy donors were
supplied by the Platform ICAReB through the cohort project
"Diagmicoll". This protocol, designed to set up new diagnostic
methods for infectious diseases, has been approved by the French
Ethical Committee (CPP Ile-de-France I including Elisabeth Frija-
Orvoe ¨n, Nadine Forest, Marc Delpech, Christophe Bardin,
Catherine Grillot-Courvalin, Franc ¸ois Dauchy, Ce ´cile Koron-
kiewcz, Jean-Michel Zucker, Lydia Morin, Catherine Labrusse-
Riou, Antoine Fourment, Marie-Annick Cornu-Thenard, Pierre
Frantz) and declared to the Research Ministry under the code
nuDC 2008-68. In the DRC all specimens were collected as part of
the routine clinical management of patients according to the
national guidelines; Institut National de Recherche Biome ´dicale
exempted this part of the study from review because the
circumstances (epidemics); verbal informed consent was obtained
from each patient; the process was documented on laboratory
booklet and the Ethics Committee of the DRC (institutional
review board included Ndelo Di Phanzu, Nguma Monganza,
Kashala Tumba Diog, Okitolonda Wemakoy, Munyanga Mu-
kungo, Kiyombo Mbela, Tshefu Kitoto, Kayembe Kalambayi,
Lapika Dimonfu, Pinda Mukumbi, Mbongo Mpasi, Rev. Pe `re
Fridolin Aubongo, Kande Buloba, Munday Mulopo) approved the
study retroactively. Animal studies were authorized by the
agreement reference 75–759 from the French Ministry of
Agriculture.
2. Development and optimization of the test
The dipstick was developed essentially as previously described
[26]. To produce mAbs against the somatic antigen of S. dysenteriae
1 [30,31], BALB/c mice were immunized intraperitonally (i.p.)
with 10
7 CFU killed S. dysenteriae 1 bacteria three times at 3-week
intervals. Mice eliciting the highest anti-LPS antibody response
were given an intravenous boost injection 3 days before being
sacrificed for splenic B cell fusion, according to Kohler and
Milstein [30].
Hybridoma culture supernatants were screened for antibody
(Ab) production by ELISA using LPS purified from S. dysenteriae 1,
as previously described [26,32,33]. Briefly, LPS purified according
to Westphal and Jann [34] was used at a concentration of 5 mg/
ml in PBS. As secondary Abs, anti-mouse IgG-, IgM peroxidase-
labeled conjugate (Sigma-Aldrich) were used at a dilution of 1/
5,000. Only the hybridoma cells secreting IgG reacting specifically
with LPS of the immunization strain, i.e., recognizing serotype-
specific determinants on the LPS O-Ag, were selected. The
selected hybridomas, representative of the four murine IgG
subclasses, were then cloned by limiting dilution, and injected
i.p. into histocompatible mice for ascitic production. IgG were
precipitated with 50% ammonium sulfate from ascitic fluid,
centrifuged, and dialyzed against PBS before being purified using
ion-exchange chromatography as previously described [32,33].
Among the available mAbs specific for S. dysenteriae 1, two IgG 2a
were selected for the development of the RDSd1 test.
The Rapid Diagnostic S. dysenteriae 1 (RDSd1) test is based on a
one-step, vertical-flow immunochromatography using mAb-cou-
pled colloidal gold particles [35]. The colloidal gold particles
(40 nm diameter) were conjugated to the F24–70 anti-S. dysenteriae
1 mAb (British Biocell International Cardiff, UK) and lyophilised
(A540 nm=2) onto polyester release pads (Accuflow P Schlei-
cher&Shull, Mantes la Ville, France). An automatic thin layer
chromatography sampler (CAMAG 5, Muttenz, Switzerland) was
used to spray the second selected anti-S. dysenteriae 1 mAb (B15–14)
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membrane (Immunopore FP, Whatmann International). In
addition, a control capture line was obtained by spraying
affinity-purified goat anti-mouse IgG (ICN Biomedical, Aurora,
Ohio, USA), on a line higher up on the strip, at a concentration of
1 mg/cm. Cellulose filter paper was used for the wicking and
sample pads (Cellulose paper 903, Schleicher&Shull). The
immunostrips were then trimmed to a width of 5 mm (Figure 1)
and stored in a waterproof bag (50 per desiccant bag) at 4uC
before to be tested on stool samples and bacterial cultures.
With bacterial cultures in broth, the test was carried out in 5 ml
disposable glass tubes at room temperature with a sample volume
of 400 al. After 10 minutes, a positive result appears as two strong
red lines (upper control line and lower S. dysenteriae 1 LPS positive
line), and a negative result as a single upper red control line
(Figure 1). S. dysenteriae strain 1 (ref. NCDC-1007-71) was used as a
positive control.
With stools, when liquid, a volume of about 400 ml (preferably
including blood, mucus, rectal sputum when present) was
transferred with a disposable pipette to a haemolysis glass tube
of 5 ml. With semisolid stools, according to the consistency of the
sample, a volume of about 200 to 400 ml of specimen was
transferred into the haemolysis tube containing 100 to 300 mlo f
distilled water. With solid stools the RDSd1 test was performed on
about 1 g of stools diluted in 400 ml of distilled water. The sample
was always homogenised by several pipettings before the immuno-
strip was introduced in the test tube. RDSd1 tests must only be
read when they are humid (never after drying) at an optimal time
that is defined for each new batch of dipsticks. This optimal time
was determined at the bench on reconstituted S. dysenteriae 1
positive stools and during a preliminary study on S. dysenteriae 1
positive and S. dysenteriae 1 negative stools.
3. Methodology of the RDSd1 test evaluation
The evaluations at the bench on strains and reconstituted stools
and the evaluation on clinical stool samples were performed
according to the STARD (Standards for Reporting of Diagnostic
Accuracy) for new assays [36].
3.1. Cut-off, reproducibility, shelf-life and specificity.
Cut-off, reproducibility, shelf-life and specificity of the dipsticks on
bacterial cultures were assessed by trained technicians. The cut-off
(detection limit) and the range of detectable LPS concentrations was
measured using two-fold dilutions (1 000 to 7.5 ng/ml of purified
LPS) and tenfold dilutions of a S. dysenteriae 1 suspensions (5610
3 to
5610
8 bacteria/ml) using saline, and reconstituted stools (10 g of
normal stool without Shigella spp suspended in 10 ml of saline). The
reproducibility of the cut-off was assessed by testing ten strips of the
same batch of RDSd1 tests simultaneously on a calibrated
suspension of the S. dysenteriae 1 strain ref 100771. To predict the
shelf-life oftheRDSd1test,weused the accelerated stabilitymethod
Figure 1. Two dispsticks showing typical negative (A) and positive (B) results after being kept for 10 minutes in bacterial cultures
(1),
watery or dysenteric stool samples.
1 The specificity was assessed using pure cultures of the following bacterial strains: S. flexneri serotypes 1a
(strain 082429), 1b (strain 085052), 2a (strain 083766), 2b (strain 082831), 3a (strain 084963), 3b (strain 083638), 4 (strain 075519), 4c (strain 08 3649), 6
var Herforshire (strain 083400), 6 var Manchester (strain 080654), Y (strain 075876) and X (strain 08 3347); S. dysenteriae serotypes 2 (strain 083092), 3
(strain 081718), 4 (strain 083171), 5 (strain 071059), 6 (strain 087336), 11 (strain 9410434), 12 (strain 080360), 13 (strain 056376) and untypable strain
97–10607, a panel of six wild S. dysenteriae 1 strains from Central Africa [38] and five S. dysenteriae 1 wild strains from Centre National de Reference
des Shigelles at Paris (strains 057331, 100771, 97171, 061306, 061305); S. boydii serotypes 1 (strain 07 7695), 2 (strain 08 3129), 3 (strain 07 8186), 4
(strain 08 3330), 5 (strain 599379), 6 (strain 346756), 8 (strain 06 6360), 9 (strain 0541), 10 (strain 081707), 11 (strain 065905), 12 (strain 06 8162),1 3
(strain 161055), 14 (strain 08 0226), 15 (strain 04 8291), 17 (strain E3615 53), 18 (strain 078115), 19 (strain 07 5636), 20 (strain 08 2360); S. sonnei strain
08 7832 (phase 1) and strain 08 7785 (phase 2); Salmonella enterica typhimurium (strains 06-2835, 06-2846, 06-2847), S enteritidis (strains 06-2841, 06-
2844, 06-2851, 06-2852), S. hadar (strains 06-2533), S. brandenburg (strain 06-2619), S. heidelberg (06-2843), S. oranienburg (strain 06-2634), S. risen
(strain 06-2615), S. stanleyville (strain 06-2832), S. typhi (strain 06-2829), S. paratyphi A (strain 06-2633), S. paratyphi B (strain 06-2696), S. meleagridis
(strain 06-2850), S. stubra (strain 06-2384), S. huittingfoss (strain 06-2391), enteroagregative Escherichia coli (strains 55989, JM221, O42, 56390 and
384P), diffusely adherent E. coli (strain AL851, AL847, C1845, AL855 and 3043), enterotoxigenic E. coli (strains EDL1496, 440TL, Tx-1, E2539-C1, 469),
enteropathogenic E. coli (strains 135/12 (O55:H-), E6468/62 (O86:H34), 11201 (O125:H6), KK111/1 and F88/6848-2 both O26:H11), E. coli O148 (ref CNR
E519-66), Vibrio cholerae O1 (strains CNRVC960255, 970002, 970014, 970025, 970067, 960325, 970022, 970053, 970055, 970056), V cholerae O139
(strains CNRVC 930008, 930381, 930210, 930190), V. cholerae non O1 and non O139 (strains CNRVC 930177, 930429, 950689, 950691, 970037, 950769,
910388, 930121, 930297, 930391), V. alginolyticus (strain CIP103336), V. fluvialis (strains CIP103355, CNRVC356), V. parahaemolyticus (strains CIP75.2,
CNRVC-030478, CNRVC030479, CNRVC000204, CNRVC000208), V. furnissii (strain CIP102972), V. hollisae (strain CIP104354), V. mimicus (strain 101888),
Aeromonas caviae (strain CIP76.16), A. enteropelogenes (strain CIP104434), A. hydrophila (strain CIP76.15), A. sobria (strain CIP74.33), Plesiomonas
shigelloides (strain CIP63.5), Campylobacter jejuni, Yersinia enterocolitica 1A (6 strains of biotype 1A, 2 strains of biotype 2, 2 strains of biotype 3, and 2
strains of biotype I). Three rough wild S. dysenteriae 1 (strains 01587, 061305, 061306) were also tested.
doi:10.1371/journal.pone.0024830.g001
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temperature [35]. The shelf-life of the strips in the laboratory was
assessed by testing a dipstick three times per week for 10 weeks after
storage at 25uC (air-conditioned room) or at 60uC (incubator). The
specificity was assessed using pure cultures of the bacteria listed in
Figure 1.
3.2. Evaluation on clinical samples. The evaluation of the
sensitivity and specificity of the RDSd1 test was performed in five
clinical studies: in India at Chandigarh, Panjab and Haryana (Post
Graduate Institute of Medical Education and Research (PGIMER)),
in Senegal at Dakar (Institut Pasteur), in Vietnam at Ho Chi Minh
City (Paediatric Hospital 1), in DRC at Kinshasa (Institut National de
Recherche Biome ´dicale), in France at the Institut Pasteur
(Investigation Clinique et Acce `s aux Ressources Biologiques) on
healthy volunteers and in the field at Komanda in the DRC. The
RDSd1 tests were shipped by air mail from France to India, Senegal,
Vietnam and the DRC at ambient temperature in grip seal bags.
Stool samples were cultured for Shigella spp and other enteric
bacterial pathogens and analyzed for parasites and viruses by using
classical methods with minor modifications according to the
laboratories [38]. Suspected colonies resembling Shigella were
identified biochemically and serotyped by slide agglutination with
monovalent O1 sera, according to the International Enterobacteri-
aceae Grouping Subcommittee [39]. When possible, samples that
were positive by the dipsticks but negative by culture were
evaluated by PCR of the ipaH gene of Shigella spp [40] and the
Shiga toxin [41] afterward.
In Chandigarh, which is an area of dysentery endemicity
involving S. dysenteriae 1, RDSd1 tests were evaluated during two
periods (April to December 2007 and June to September 2009) of
high incidence of the disease [37]. In 2007, 92 stools samples were
collected during an outbreak of diarrhea and 40 from sporadic
cases of dysentery, all from patients living in slums around
Chandigarh. A total of 10 stool samples were collected from
sporadic cases of dysentery in patients admitted to local
dispensaries and in district hospitals in Chandigarh and the
nearby states of Panjab and Haryana. In 2009, 43 stools were
collected from patients consulting PGIMER for diarrheal disease.
All these 185 stool samples were collected in sterile screw capped
containers and immediately transported to the Medical Labora-
tory in PGIMER for diagnosis by classical methods by a trained
technician. In 2007, aliquots of each of the 142 stools collected
were frozen. A total of 86 frozen stool samples in which the
aetiology was known were made available for this evaluation study
from the specimen bank of the PGIMER. Stools were encoded.
The RDSd1 tests were performed on defrosted stools by another
trained technician. Results obtained with stool cultures for enteric
pathogens and RDSd1 tests were then compared. In 2009, the
second study was performed on 43 diarrheal fresh stools; stool
cultures and the RDSd1 test were performed by two different
technicians and the results were then compared.
In Dakar, the study was performed from June to August 2008.
We compared the results obtained with stool cultures for
enteropathogenic bacteria, viruses and parasites, and dipsticks
performed in a blind study by two different technicians. A total of
75 stool samples from infants referred to the microbiology
laboratory of Institut Pasteur of Dakar were collected. The
dipstick test was performed by one technician and the stool
samples were then tested for diagnosis by classical methods by
another technician. Results obtained with stool cultures and
dipsticks were then compared.
In France, 24 non-diarrheic stools from healthy volunteers
consulting the Plate-Forme Investigation Clinique et Acce `s aux
Ressources Biologiques (Institut Pasteur, Paris) were tested from
February to April 2010. RDTSd1 were read by two persons and
the results were compared at the end of the study.
In Ho Chi Minh City, a total of 53 stool samples from infants
who had severe diarrhoea were collected and tested in the
Paediatric Hospital I from November 2009 to March 2010. In a
blind study, the results obtained with stool cultures and the RDSd1
tests performed by two different technicians were compared.
Samples were then stored at -20uC.
In the DRC, during an outbreak of bloody diarrhoea at
Zunguluka, district of Boga (Ituri, East Province) that occurred
in July 2009, lactose-negative bacteria were isolated from 12
diarrhoeal stools in the laboratory of Ituri in the city of Bunia
(located about 1 000 kms –East- of Kinshasa, 01u34916.0
North/030u14910.0 East) and sent to INRB in Kinshasa to be
identified. Among these 12 stools, five were tested by using
RDSd1 test in the laboratory. Strains sent to INRB were tested
by using both RDSd1 tests and classical bacteriological methods
for Enterobacteriaceae. In August 2009, during an outbreak of
watery diarrhea at Ofaye, district of Komanda (Ituri, East
Province) (01u13910.40 North/029u419350 East), RDSd1 tests
were sent from INRB to the laboratory of Ituri in the city of
Bunia (Laboratoire Me ´dical de Re ´fe ´rence de l9Ituri a `B u n i a )t o
be used in the field. A total of 43 stools were collected from
adults and infants by using sterile screw-capped containers,
transferred to 5 ml test tubes by using plastic pipettes
(Pasteurette) and then subjected to the RDSd1 test. The
collected stools were also preserved in Cary Blair and sent to
the laboratory of Ituri in the city of Bunia. Lactose-negative
colonies were isolated, preserved in Cary Blair medium and sent
to Kinshasa to be identified at INRB. Results obtained with
stool cultures and dipsticks were then compared.
3.3. Statistics. We calculated the sensitivity (Se), which is the
proportion of specimens with the target disorder in which the test
result is positive; and the specificity (Sp), which is the proportion of
specimens without the target disorder in which the test result is
negative. The 95% confidence intervals (CI) for Se and Sp were
determined [42]. We also calculated the Cohen’s kappa (a) statistic
[43] to measure concordance between stool culture and the RDSd1
test in the five prospective clinical studies. a may range from 0 to 1,
and a a value of or higher than 0.8 is considered to indicate almost
perfect agreement [44]. We also calculated likelihood ratios (LR).
The positive LR (LR+ = Se/[1 - Sp]) indicates how many times a
positive result is more likely to be observed in specimens with the
target disorder than in those without the target disorder. The
negative LR (LR- = [1 - Se]/Sp) indicates how many times a
negative result is more likely to be observed in specimens with the
target disorder than in those without the target disorder. Accuracy
increases the more the LR differs from 1. LR+ above 10 and LR-
below 0.1 were considered convincing diagnostic evidence [45].
The diagnostic odds ratio (DOR), defined as the ratio of the odds of
positive test results in specimens with the target disorder relative to
the odds of positive test results in specimens without the target
disorder, was calculated as follows [46]: DOR = (Se/[1 - Se])/([1 -
Sp]/Sp). The DOR does not depend on prevalence and its value
ranges from 0 to infinity, with higher values indicating better
discriminatory test performance. The positive predictive value
(PPV) represents the proportion of test-positive specimens that truly
present the target disorder, while the negative predictive value
(NPV) represents the proportion of test-negative specimens that
truly do not present the target disorder: PPV = (P 6 Se)/(P 6
Se)+[(1- P)6(1 – Sp)] and NPV = (1 - P)6Sp/[(1- P)6Sp]+[P6
(1 - Se)]. P is the prevalence of the target disorder in the population
of specimens to which the test is applied. The 95% CI for PPV and
NPV were also determined [45].
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1. Cut-off, reproducibility and specificity on bacterial strains
The lower detection threshold of the dipstick for S. dysenteriae 1
LPS was 15 ng/ml in both distilled water and in reconstituted
stools. Similar results were obtained using dipsticks stored for 22
days at 56uC. No prozone effect (i. e. no signal detected for high
concentrations) was observed by using a range of LPS concentra-
tions extending from 10 ng/ml to 1 mg/ml. In addition, in
distilled water and in reconstituted stools containing different
concentrations of S. dysenteriae 1, an unequivocal positive reaction
was obtained in 2 minutes with 1.6610
6 CFU/ml and
4.9610
6 CFU/ml of S. dysenteriae 1, respectively (Figure 1). These
detection limits were reproduced ten times. The specificity of the
dipstick was 100% for all bacterial cultures with smooth strains
listed in Figure 1. RDSd1 tests were negative with the three rough
S. dysenteriae 1 strains.
2. Optimal time to read the test
For bacterial cultures, the lower test line appeared in 1 to 2
minutes and the upper control line appeared 5–6 minutes later.
On stools, for positive samples, the strong red lower positive line
appeared in 2 to 3 minutes and a similar colour appeared on the
upper control line 6 to 7 minutes later (Figure 1). With semisolid
samples and stools containing mucus with a lower fluidity than
bacterial cultures, the time required for soaking the dipstick was
longer; consequently, the optimal delay to read the RDSd1 test
was fixed at 10 minutes. During a preliminary study performed in
India on 75 S. dysenteriae 1 negative liquid stools, a faint yellow or
purple band was observed on the lower test line before the tenth
minute on 25 (33.3 %) RDSd1 tests, and on 2 (2.6 %) after drying
(Figure 2). For these reasons it has been stated that RDSd1 tests
must never be interpreted over the defined optimal time for test
and control lines, and never after drying. A sample is reported as
positive if there is pink to red colour on the test line and on the
control line in the optimal time.
3. Comparative prospective clinical studies
In the first study performed in Chandigarh, of the 86 patients
from whom the stools were taken for the evaluation study the
clinical characteristics of 85 patients are shown in Table 1. Clinical
characteristics were not available for one RDSd1 test-and culture-
positive patient. Of these 86 stool samples from patients in
Chandigarh, 74 were both RDSd1 test-and culture-negative, 11
were RDSd1 test-positive before the tenth minute and culture-
positive, and 1 was RDSd1 test-negative in the defined optimal time
and stool culture positive. This last sample was clearly read dipstick-
positive at the thirteenth minute. In the second study in 2009, all the
43 stools were both RDSd1 test and culture-negative. Among the
117RDSd1testsusedonS.dysenteriae1 negativestools,afaintyellow
test band was observed before the tenth minute on 25 (21.4 %)
RDSd1 tests and after the tenth minute on 5 (4.3 %) RDSd1 tests. A
faint pink band on the test line was observed in one stool culture-
negative sample after the dipstick was dried out of the test tube.
These RDSd1 tests were interpreted as negative by the user.
Of the stool samples from patients in Dakar, 75 (100 %) were
both RDSd1 test-and culture-negative. Faint yellow test bands
appeared on 12 (16 %) dipsticks, and slight pink colour appeared
on 8 (10.7 %) dipsticks after the optimal time; these 20 RDSd1
tests were interpreted as negative.
In Ho Chi Minh City, no S. dysenteriae 1 was isolated from the 53
studied stools. In one case the RDSd1 test failed (no colour on the
control line) and was excluded from calculations. In 4 cases, the
RDSd1 test was positive. A faint purple test band was observed on
3 negative S. dysenteriae 1 stools several minutes after the upper
control line appeared and a very faint purple test band was
observed in 8 (15 %) negative S. dysenteriae 1 stools in the prescribed
time. These 11 RDSd1 tests were interpreted as negative.
In France, 24 stools were both RDSd1 test-and S. dysenteriae 1
culture-negative. A faint yellow test band was observed on 3 (12.5
%) dipsticks and on 3 other after drying. These 6 RDSd1 tests
were interpreted as negative.
In DRC, during the first epidemic at Zunguluka, all the RDSd1
tests were negative on the stools and on the lactose-negative non S.
dysenteriae 1 strains received and identified at INRB by classical
methods. The 43 RDSd1 tests done in the field during the second
epidemic were interpreted as negative by non-experienced health
workers. No indeterminate results due to faint yellow colour (or
another colour) on the test line was reported by the field
technician.
Figure 2. Two dipsticks showing a negative reaction with a faint yellow band appeared before or after the optimal time of 10
minutes to read the test (A) and after drying (B).
doi:10.1371/journal.pone.0024830.g002
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(Table 2), specificity (312/316) was therefore 98.7% (95% CI:
96.6%–99.6%), the sensitivity (11/12) was 91.7% (95% CI: 59.8%
– 99.6%). Stool cultures and RDSd1 tests gave concordant results
in 98.4 % of cases (323/328) in the comparative studies. The
Kappa coefficient obtained in this study was 0.8 ([0.984 – 0.921]/
[1 – 0.921]). For the RDSd1 test, the LR+ was 70.5 and the LR-
was 0.084, and the DOR was 839. The PPV (11/15) was 73.3%
(95% CI: 44.8% – 91.1%) and the NPV (312/313) was 99.7%
(95% CI: 98% – 100%). The variations of the PPV and the NPV
according to prevalence were determined using the Se and Sp for
clinical stool samples (Figure 3).
Discussion
S. dysenteriae 1 dysentery is often fatal without prompt and
appropriate treatment [4-12]. Indeed, it causes a more severe and
prolonged illness, particularly in young children, infants, the
elderly, and the malnourished, than do infections with other
Shigella serogroups [3,5,7]. Late diagnosis is one of the major
causes of human death and spread of the disease since it limits the
effectiveness of control measures. The review of the situation with
regard to shigellosis led to a revision of the World Health
Organisation guidelines for the control of bacillary dysentery [47].
The development of a reliable rapid diagnostic assay for improving
diagnosis and surveillance is among the main modifications
brought to these guidelines [22,48]. The use of PCR assays based
on the amplification of the invasion plasmid antigen H (ipaH) and
Shiga toxin (Stx) gene sequences can overcome some of the
shortcomings of culture methods but the method itself has not yet
received global acceptance due to difficulties in its implementation
in structures lacking microbiological support. The conventional
culture methods currently used for diagnosis of S. dysenteriae 1
remains the gold standard but require a functioning laboratory
and are time-consuming. Immunological methods for diagnosis of
Shigella in stool samples have been studied [49,50,51,52].
At this stage of the study, the RDSd1 test we developed and pre-
evaluated has the following characteristics: quick time-to-answer,
simple readout, able to be used by minimally trained personnel,
the ability to function at 30u C and at high humidity, the ability to
be stored for two years without refrigeration, the ability to conduct
tests without the need for specific laboratory reagents (only water)
or specialized laboratory equipment. The RDSd1 test was found
to be highly specific when tested on bacterial cultures, with a better
Table 1. Clinical characteristics of patients from India (Chandigarh).
Characteristics With S. dysenteriae 1 Others
(n=11) (n=74)
Age (yr)
,5 2 (16.7) 23 (31.1)
6–14 2 (16.7) 17 (22.9)
15–45 6 (50) 23 (31.1)
45 and . 1 (8.3) 11 (14.9)
Mean+/2 SD 24.5+/221.6 19.7+/220.02
Range 11 months to 75 yrs 5 days to 75 yrs
Watery Stool 8 (66.7) 62 (83.8)
Dysenteric stool (blood + mucus) 3 (25) 12 (16.2)
Vomiting 5 (41.7) 32 (43.2)
Fever 11 (91.7) 29 (39.2)
Abdominal pain 10 (83.3) 32 (43.2)
Duration of diarrhea
,1 0 (0) 1 (1.35)
1–3 7 (58.3) 52 (70.2)
4–6 2 (16.7) 9 (12.2)
6–15 0 (0) 4 (5.4)
.15 2 (16.7) 8 (10.8)
Dehydration status
None 7 (58.3) 51 (69)
Some 3 (25) 17 (22.9)
Severe 1 (8.3) 6 (8.1)
Duration of stay at hospital or dispensary (h)
0–11 0 (0) 11 (15)
12–23 2 (16.7) 5 (6.7)
24–47 1 (8.3) 15 (20.3)
48–95 3 (25) 25 (33.8)
96+ 5 (41.7) 18 (24.3)
doi:10.1371/journal.pone.0024830.t001
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6 CFU/ml of S. dysenteriae 1 and
15 ng/ml of LPS) than dipstick tests developed to diagnose cholera
(10
7 CFU/ml of V. cholerae O1 and 50 ng/ml of LPS) [18,33,25]
and S. flexneri 2a infection (5610
7 CFU/ml, 20 ng/ml of LPS)
[18,33,25]. Importantly, although the E. coli O148 O antigen
repeating unit was shown to differ from that of S. dysenteriae type 1
only by the presence of a glucose residue in place of the galactose
residue [30], no cross reaction was observed with E. coli
O148:H28, which is one of the most common causes of diarrhoea
in children in developing countries as well as in travellers to these
areas [53].
This preliminary RDSd1 test evaluation on stools of patients
living in endemic and non-endemicareas verified its high specificity.
The RDSd1 test and stool cultures gave concordant results in 98.4
% and the kappa coefficient (0.8) obtained reflecting the good
agreement. The NPVand the PPVexceeded 75 %, even duringlow
prevalence of the disease. The public health implications of a very
specific assay are greater in areas where the bacillary dysentery due
to this serotype is rare than in countries were the disease is endemic,
and a highly specific assay is most valuable to rule out S. dysenteriae 1
dysentery in an individual patient.
Given that antimicrobial therapy is recommended for all
patients presenting symptoms of dysentery, the clinical significance
of a positive rapid diagnostic S. dysenteriae 1 assay is high.
Regarding the sensitivity of 91.7 %, the most likely explanation
for the single discrepancy observed in India could be a very low
concentration of S. dysenteriae 1 or LPS in the stool sample (because
the test line was positive later, at the thirteenth minute). In
Vietnam, among the four discordant results, it was not possible for
one of them to conclude if there were co-infections because no
PCR specific for S. dysenteriae 1 was available; in the three other
samples, the presence of PCR inhibitors was suspected, but false-
positive results with the RDSd1 test cannot be excluded. The
dipstick test is sensitive enough when the lower test line is read at
the third minute and when the upper control line is read seven
minutes later. The sensitivity could be enhanced by reading after a
longer time but we decided the optimal time is 10 minutes to avoid
the potential risk of false positive results. In ten minutes, the great
majority of the samples reached the wicking pad at the top of
the dipstick. These two times depend on the distances between the
sample pad and the test line, and between the sample pad and the
control line. The shorter the distance, the shorter is the time of
response.
Figure 3. Predictive values (PV) for Shigella dysenteriae 1
diagnosis. Positive PV is represented by the red line and negative
PV by the blue line.
doi:10.1371/journal.pone.0024830.g003
Table 2. Detection of S. dysenteriae 1 in 328 stool samples by RDSd1 test versus conventional culture.
Bacteriological culture N6 of specimens with S. dysenteriae 1 dipstick test result
Positive Negative Total
Positive 11 (India) 1 (India) 12
Negative 4 (Vietnam)
5 74 (India 2007)
1 316
43 (India 2009)
2
75 (Senegal)
3
48 (DRC)
4
48 (Vietnam)
6
24 (France)
7
Total 15 313 328
1- 22 cultures were positive for S. flexneri,2 0f o rVibrio cholerae O1, 5 for Enteroaggregative E. coli, 3 for Salmonella enterica, 2 for Enterotoxigenic E. coli, 2 for Aeromonas
spp, 1 for Enteropathogenic E. coli, 1 for Clostridium difficile, 1 for Pseudomonas aeruginosa, 1 for Cryptosporidium parvum. In 52 RDSd1 test-negative samples Shigella
spp was not isolated; on 38 of these samples IpaH PCR and Shiga toxin PCR were negative. For technical reasons (insufficient amount of stools, problems of storage),
PCR was not done on 14 samples.
2- A total of 14 cultures were positive for V. cholerae O1, 1 for S. flexneri, and 1 for Enteroaggregative E. coli.
3- 30 stools were positive for parasites (8 Endolimax nana,6E. coli,3Giardia lamblia,1E. histolytica,1Trichuris trichiura,1Hymenolepis nana,7E. nana and E. coli,1E.
nana and Trichuris trichiura,1E. nana and E. histolytica,1E. nana and Ascaris lumbricoides).
4– During the first epidemic in Boga; 5 Salmonella enterica were identified among the lactose-negative strains received and studied at INRB. During the second epidemic
at Ofaı ¨, lactose-negative strains isolated at the dispensary of Bunia and sent to INRB were identified as Salmonella enterica.
5- In one of these 4 samples, an Enteroinvasive E. coli and a classical Enteropathogenic E. coli were identified. No enteric pathogen was identified in the other 3 samples
that were IpaH PCR negative.
6- 1 culture was positive for S. sonnei, 6 were positive for diarrheogenic E.coli (4 Diffusely Adhering E. coli, 1 Enteroinvasive E. coli, 1 with both Diffusely Adhering E. coli
and Enteroinvasive E. coli) and 2 for Salmonella enterica.
7– No pathogen was identified.
doi:10.1371/journal.pone.0024830.t002
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outbreak of S. dysenteriae 1 dysentery. At the beginning of an
outbreak, critical interventions for S. dysenteriae 1 dysentery control
include improved access to efficient treatment facilities, education
to promote good personal hygiene, and improvement of sanitation
and safe water supply. Successful interventions depend on early
and easy detection of index cases. However, a suspected outbreak
of S. dysenteriae 1 dysentery, whether detected by a rapid diagnostic
assay or clinical diagnosis, should be confirmed with a stool culture
from a sample of a typical patient. Culture confirmation will allow
characterizing S. dysenteriae 1 strains and antimicrobial susceptibil-
ity testing to be performed on isolates in order to guide treatment.
Furthermore, without assistance from a laboratory or a specific
test, healthcare providers who are less accustomed to seeing
patients with bacillary dysentery may have difficulties with
differentiating bacillary dysentery from amoebiasis that presents
quite similar symptoms but requires antiprotozoal therapy.
Although data from this preliminary evaluation on stool samples
from patients living in endemic and non-endemic areas are
encouraging, we need more positive stool specimens to definitively
conclude on the sensitivity of the RDSd1 test. To estimate
sensitivity of the dipstick with its 95% CI, a total of 100 S.
dysenteriae 1 culture positive samples are needed in the evaluation
panel. This full evaluation of the RDSd1 test faces the problem of
the actual, but probably temporary, low prevalence of the disease
in the world. A large-scale study comparing stool culture and
RDSd1 test is warranted in the future.
Clinical data were only available for 85 patients recruited at
Chandigarh. Interestingly, in this area, severe and milder forms of
dysentery were developed by patients and included in the study.
Dysenteric patients infected by S. dysenteriae 1 have generally a severe
form of shigellosis with a clinical spectrum ranging from watery
diarrhoea at the early stage of the infection to diarrhoea with mucus
and frank bloody diarrhoea with fever beginning generally the third
day of the infection. Bloody diarrhoea is associated with the rupture
of the intestinal epithelial barrier, followed by the invasion and
destruction of the intestinal mucosa, resulting in the proliferation of
the pathogens faster than that occurring in patients with a milder
form of the disease [54]. Patients who have the most severe form of
shigellosis also shed a higher number of microorganisms [54]. A
direct relationship between bacterial load (i. e. LPS concentration in
stools), detection by culture, and disease severity also exists [54].
Consequently, it is essential to develop an efficient RDSd1 test that
displays a low detection threshold and detects the somatic antigen
without prozone effect to avoid false-negative results in samples
containing high concentrations of S. dysenteriae 1 LPS antigen. We
report here such a tool.
The dipstick must be read when it is humid and never after
drying. A yellow faint or purple band appeared in the prescribed
time on the test line of some dipsticks (17 %) tested on S. dysenteriae
1 negative sample. This phenomenon has been also observed for
rapid diagnostic tests developed for cholera [55]. In our experience
in the DRC, by informing of this phenomenon on the notice
instruction, negative results were correctly read by the field
technician working in the dispensary of Bunia. Because of the clear
difference between the faint yellow or purple colour and the strong
red or pink positive colour of the positive test band and of the
control band, there was no misinterpretation by the operators
during the study; furthermore the time to read the test was strictly
respected, which is essential. An optimal time must be determined
with each new batch of RDSd1 test. Investigations are in progress
to know the origin of these faint or purple yellow colours observed
on some test lines. We hypothesize that they may be a product of
heme catabolism or are linked to the food regime.
This diagnostic test has been used in Chandigarh, Dakar, Ho Chi
Minh City, Kinshasa and Paris, all sites with microbiological
diagnosis infrastructures. The experience in the DRC at Bunia
showed that a field technician could perform the dipstick assay in the
dispensary and in the field (in the tropical forest) at least as well as was
doneinthelaboratory,withoutspecifictrainingandonlybyfollowing
the technical notice; however, we need to confirm through other
studies that these findings can be extrapolated to all laboratories and
to field sites under different working conditions. According to this
particular healthcare worker in the DRC, the dipsticks are easy to use
in the field and after the test are performed, all the material can be
sterilized either by chlorineor by burning themtoavoid further risk of
contamination. Data can be stored by digital photography.
Consideringthepotentialimpactthisrapiddiagnostictestwillhave
for the clinical management of the diseaseand for earlydetection of S.
dysenteriae 1 dysentery outbreaks, our group wishes to quickly develop
collaborations with institutions located in areas in the developing
world where S. dysenteriae 1 bacillary dysentery is endemo epidemic to
definitively validate this RDSd1 test. Such a rapid diagnostic test
could also allow better understanding of the burden of disease caused
by this organism, therefore improving the evaluation of interventions.
This diagnostic test has been mainly evaluated on sites with a
microbiological diagnosis infrastructure. Although we have an
experience in the field in the DRC, these findings cannot necessarily
be extrapolated to sites where most reported bacillary dysentery cases
occur. As it was previously realized for the immunochromatographic
dipstick test specific for V. cholerae O1 [56], we therefore need to
evaluate the RDSd1 test in an endemic setting typical of many urban
or rural areas of developing countries and use conventional
bacteriological culture as the reference standard.
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